OriGen is announcing a change to the Percutaneous Introducer Products. The new PCT Kit (Part Code: PCT) is designed to minimize the cut-down on the ju...
Read More
Inc. Magazine has once again named OriGen Biomedical to its Inc. 5000 list of the fastest growing privately-owned companies in America for 2016, with ...
Read More
Inc. Magazine named OriGen Biomedical to its 2015 list of the fastest-growing privately-owned companies in America with a rank of #4142. Now a five-ti...
Read More
OriGen Biomedical named #37 by Fortune Magazine and the Initiative for a Competitive Inner City (ICIC) in the 2014 ICIC 100 and #3 in the Healthcare &...
Read More
The list, started in 1982, ranks the most successful private companies in the United States; this is OriGen’s 4th year on the Inc 500/5000.
Read More
The Aggie 100 is an annual award that recognizes the 100 fastest-growing companies in the world that are owned or led by Texas A&M University alum...
Read More
AUSTIN, June 2013: OriGen Biomedical, Inc. announced the acquisition of Alliance Pharmaceutical Corp.’s, San Diego, CA, LiquiVent® clinical trial data...
Read More
Inc. Magazine ranked OriGen #885 in its Annual 2012 Inc. 500/5000 list. This ranks the nation’s fastest-growing private companies. This is our s...
Read MoreReinforced Dual Lumen Cannula approved by the FDA – 13F available for sale, other sizes coming soon!
Read More
OriGen’s facility at 7000 Burleson Rd, Bldg D Austin, TX 78744 expands to 45,000 SF (4180 M2) – adding two additional clean rooms; one fo...
Read More